Share 'Drisapersen Regulatory Discussions Ongoing & Re-Dosing on Track'
Below you can find the latest update from Prosensa regarding a potential regulatory path forward for drisapersen.Regulatory discussions ongoing & re-dosing on track
Dear Patient Group Representative,
Leiden, May 22 2014
We trust this letter finds you well. As announced in a press release and during our quarterly update for the financial community on May 20, we are encouraged by our ongoing i…
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this